| First Author | Tomlinson KL | Year | 2023 |
| Journal | Cell Metab | Volume | 35 |
| Issue | 10 | Pages | 1767-1781.e6 |
| PubMed ID | 37793346 | Mgi Jnum | J:355008 |
| Mgi Id | MGI:7540264 | Doi | DOI: 10.1016/j.cmet.2023.09.001 |
| Citation | Tomlinson KL, et al. (2023) Ketogenesis promotes tolerance to Pseudomonas aeruginosa pulmonary infection. Cell Metab 35(10):1767-1781.e6 |
| abstractText | Pseudomonas aeruginosa is a common cause of pulmonary infection. As a Gram-negative pathogen, it can initiate a brisk and highly destructive inflammatory response; however, most hosts become tolerant to the bacterial burden, developing chronic infection. Using a murine model of pneumonia, we demonstrate that this shift from inflammation to disease tolerance is promoted by ketogenesis. In response to pulmonary infection, ketone bodies are generated in the liver and circulate to the lungs where they impose selection for P. aeruginosa strains unable to display surface lipopolysaccharide (LPS). Such keto-adapted LPS strains fail to activate glycolysis and tissue-damaging cytokines and, instead, facilitate mitochondrial catabolism of fats and oxidative phosphorylation (OXPHOS), which maintains airway homeostasis. Within the lung, P. aeruginosa exploits the host immunometabolite itaconate to further stimulate ketogenesis. This environment enables host-P. aeruginosa coexistence, supporting both pathoadaptive changes in the bacteria and the maintenance of respiratory integrity via OXPHOS. |
